Insider · CIK 0001770436
Aron R. English
Files at FSTR (FOSTER L B CO), CULP (CULP INC), LFCR (LIFECORE BIOMEDICAL, INC. \DE\), SRI (STONERIDGE INC), DRTTF (DIRTT ENVIRONMENTAL SOLUTIONS LTD), ANEB (Anebulo Pharmaceuticals, Inc.). First filing Dec 11, 2024, latest Apr 2, 2026.
In brief
Aron R. English files SEC Form 4 as 10% owner and director at FSTR (FOSTER L B CO), and also at CULP (CULP INC), LFCR (LIFECORE BIOMEDICAL, INC. \DE\), ANEB (Anebulo Pharmaceuticals, Inc.), SRI (STONERIDGE INC) and 1 more. Since Dec 11, 2024, Aron R. English has reported 6 open-market buys worth $11M and 14 open-market sells worth $18M, the latest filed on Apr 2, 2026.
A track record needs three past buys with six months of prices behind them; Aron R. English has 1, so none is measured yet.
The newest scored trade: sold $1.1M of FSTR on Mar 31, 2026, filed Apr 2, 2026, scored 37 (weak). In the last 12 months: 0 buys worth $0 and 10 sells worth $7.9M.
Where the trades landed
Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.
FSTR: FOSTER L B CO
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CULP: CULP INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
LFCR: LIFECORE BIOMEDICAL, INC. \DE\
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | FSTRsell FOSTER L B CO | $1.1M 39,931 shares | -4% | +55% from low-13% from high | |
| 27Weak | FSTRsell FOSTER L B CO | $328k 11,717 shares | -1% | +56% from low-13% from high | |
| 37Weak | FSTRsell FOSTER L B CO | $3.0M 107,019 shares | -9% | +56% from low-13% from high | |
| 23Weak | FSTRsell FOSTER L B CO | $164k 5,124 shares | -0% | - | |
| 37Weak | FSTRsell FOSTER L B CO | $1.3M 47,537 shares | -4% | - | |
| 33Weak | FSTRsell FOSTER L B CO | $697k 25,813 shares | -2% | - | |
| 18Weak | FSTRsell FOSTER L B CO | $38k 1,408 shares | -0% | - | |
| 43Moderate | FOSTER L B CO | $863k 32,140 shares | -2% | - | |
| 28Weak | FOSTER L B CO | $71k 2,647 shares | -0% | - | |
| 35Weak | FOSTER L B CO | $346k 12,530 shares | -1% | - | |
| 57Moderate | LFCRsell LIFECORE BIOMEDICAL, INC. \DE\ | $9.1M 1,386,060 shares | -84% | +50% from low-13% from high | |
| 21Weak | LFCRsell LIFECORE BIOMEDICAL, INC. \DE\ | $86k 12,334 shares | -1% | +55% from low-10% from high | |
| 27Weak | LFCRsell LIFECORE BIOMEDICAL, INC. \DE\ | $362k 51,496 shares | -3% | +53% from low-11% from high | |
| 26Weak | LFCRsell LIFECORE BIOMEDICAL, INC. \DE\ | $290k 41,091 shares | -2% | +56% from low-10% from high | |
| 54Moderate | CULP INC | $672k 124,738 shares | +7% | +25% from low-16% from high | |
| 41Moderate | CULP INC | $117k 23,019 shares | +1% | +14% from low-24% from high | |
| 61Notable | CULP INC | $428k 86,589 shares | +5% | +7% from low-28% from high | |
| 50Moderate | ANEBbuy Anebulo Pharmaceuticals, Inc. | $10.0M 10,101,010 shares | +188% | - | |
| 44Moderate | CULP INC | $70k 13,444 shares | +1% | +8% from low-20% from high | |
| 31Weak | CULP INC | $85k 16,881 shares | +1% | - |
Transactions
The newest 50 of 60 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -1,500 | $28.02 | $42k | 1,065,686 | Apr 2, 2026 |
| Apr 1, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -38,431 | $28.05 | $1.1M | 1,027,255 | Apr 2, 2026 |
| Mar 26, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -8,968 | $28.02 | $251k | 1,069,935 | Mar 30, 2026 |
| Mar 27, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -862 | $28.02 | $24k | 1,069,073 | Mar 30, 2026 |
| Mar 30, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -1,887 | $28.01 | $53k | 1,067,186 | Mar 30, 2026 |
| Mar 23, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -78,414 | $28.51 | $2.2M | 1,107,508 | Mar 25, 2026 |
| Mar 24, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -25,889 | $28.19 | $730k | 1,081,619 | Mar 25, 2026 |
| Mar 25, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -2,716 | $28.09 | $76k | 1,078,903 | Mar 25, 2026 |
| Mar 16, 2026 | SRI STONERIDGE INC | AGrant or award Common Shares, without par value | +23,478 | $0.00 | $0 | 23,478 | Mar 18, 2026 |
| Mar 4, 2026 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -5,124 | $31.99 | $164k | 1,185,922 | Mar 6, 2026 |
| Dec 11, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -34,025 | $26.79 | $912k | 1,204,558 | Dec 12, 2025 |
| Dec 12, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -13,512 | $26.79 | $362k | 1,191,046 | Dec 12, 2025 |
| Dec 8, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -9,765 | $27.28 | $266k | 1,254,631 | Dec 10, 2025 |
| Dec 9, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -4,800 | $26.93 | $129k | 1,249,831 | Dec 10, 2025 |
| Dec 10, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -11,248 | $26.83 | $302k | 1,238,583 | Dec 10, 2025 |
| Nov 28, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -1,307 | $27.09 | $35k | 1,264,497 | Dec 2, 2025 |
| Dec 1, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -101 | $26.82 | $2,709 | 1,264,396 | Dec 2, 2025 |
| Nov 21, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -3,412 | $27.03 | $92k | 1,294,532 | Nov 25, 2025 |
| Nov 24, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -27,003 | $26.84 | $725k | 1,267,529 | Nov 25, 2025 |
| Nov 25, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -1,725 | $26.94 | $46k | 1,265,804 | Nov 25, 2025 |
| Nov 14, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -2,247 | $27.00 | $61k | 1,298,344 | Nov 18, 2025 |
| Nov 17, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -400 | $27.00 | $11k | 1,297,944 | Nov 18, 2025 |
| Nov 11, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -4,813 | $28.17 | $136k | 1,308,308 | Nov 13, 2025 |
| Nov 11, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -2,749 | $27.52 | $76k | 1,305,559 | Nov 13, 2025 |
| Nov 12, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -3,368 | $27.06 | $91k | 1,302,191 | Nov 13, 2025 |
| Nov 13, 2025 | FSTR FOSTER L B CO | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -1,600 | $27.00 | $43k | 1,300,591 | Nov 13, 2025 |
| Aug 29, 2025 | DRTTF DIRTT ENVIRONMENTAL SOLUTIONS LTD | MOption exercise Common Shares | +773,026 | - | - | 8,265,969 | Sep 2, 2025 |
| Aug 29, 2025 | DRTTF DIRTT ENVIRONMENTAL SOLUTIONS LTD | DDisposition to issuer Common Shares | -182,144 | $0.52 | $95k | 8,083,825 | Sep 2, 2025 |
| Aug 29, 2025 | DRTTF DIRTT ENVIRONMENTAL SOLUTIONS LTD | MOption exercise Deferred Share Unitderivative | -773,026 | - | - | 0 | Sep 2, 2025 |
| Jul 29, 2025 | DRTTF DIRTT ENVIRONMENTAL SOLUTIONS LTD | AGrant or award Deferred Share Unitderivative | +17,634 | $0.68 | $12k | 773,026 | Jul 31, 2025 |
| Jun 30, 2025 | DRTTF DIRTT ENVIRONMENTAL SOLUTIONS LTD | AGrant or award Deferred Share Unitderivative | +62,543 | $0.60 | $38k | 755,391 | Jul 2, 2025 |
| May 23, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -96,137 | $6.75 | $649k | 1,554,103 | May 28, 2025 |
| May 27, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -1,139,504 | $6.50 | $7.4M | 414,599 | May 28, 2025 |
| May 28, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -150,419 | $7.12 | $1.1M | 264,180 | May 28, 2025 |
| May 13, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -12,334 | $7.00 | $86k | 1,650,240 | May 16, 2025 |
| May 8, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -5,098 | $7.00 | $36k | 1,708,972 | May 12, 2025 |
| May 9, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -700 | $7.00 | $4,900 | 1,708,272 | May 12, 2025 |
| May 12, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -45,698 | $7.03 | $321k | 1,662,574 | May 12, 2025 |
| May 5, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -24,543 | $7.08 | $174k | 1,730,618 | May 7, 2025 |
| May 6, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -701 | $7.05 | $4,940 | 1,729,917 | May 7, 2025 |
| May 7, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -15,847 | $7.01 | $111k | 1,714,070 | May 7, 2025 |
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Apr 7, 2025 |
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +2,647 | $0.00 | $0 | 2,647 | Apr 7, 2025 |
| Mar 31, 2025 | DRTTF DIRTT ENVIRONMENTAL SOLUTIONS LTD | AGrant or award Deferred Share Unitderivative | +51,588 | $0.73 | $37k | 692,849 | Apr 3, 2025 |
| Mar 18, 2025 | CULP CULP INC | POpen-market purchase Common Stockindirect: By: 22NW Fund, LP | +104,738 | $5.35 | $560k | 1,839,061 | Mar 20, 2025 |
| Mar 19, 2025 | CULP CULP INC | POpen-market purchase Common Stockindirect: By: 22NW Fund, LP | +20,000 | $5.60 | $112k | 1,859,061 | Mar 20, 2025 |
| Mar 13, 2025 | CULP CULP INC | POpen-market purchase Common Stockindirect: By: 22NW Fund, LP | +9,793 | $5.07 | $50k | 1,721,097 | Mar 17, 2025 |
| Mar 14, 2025 | CULP CULP INC | POpen-market purchase Common Stockindirect: By: 22NW Fund, LP | +9,006 | $5.08 | $46k | 1,730,103 | Mar 17, 2025 |
| Mar 17, 2025 | CULP CULP INC | POpen-market purchase Common Stockindirect: By: 22NW Fund, LP | +4,220 | $5.17 | $22k | 1,734,323 | Mar 17, 2025 |
| Mar 10, 2025 | CULP CULP INC | POpen-market purchase Common Stockindirect: By: 22NW Fund, LP | +13,849 | $4.65 | $64k | 1,638,564 | Mar 12, 2025 |
Questions about Aron R. English
Answered from the filings on this page, as of the latest one.
Is Aron R. English buying or selling?
In the last 12 months Aron R. English reported 0 open-market buys worth $0 and 10 open-market sells worth $7.9M on SEC Form 4; the latest was sold $1.1M of FSTR on Mar 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Aron R. English's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Aron R. English has 1.
Where does Aron R. English file Form 4?
Aron R. English has filed Form 4 at FSTR (FOSTER L B CO); CULP (CULP INC); LFCR (LIFECORE BIOMEDICAL, INC. \DE\); ANEB (Anebulo Pharmaceuticals, Inc.); SRI (STONERIDGE INC) and 1 more. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.